| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| 營業收入 | 58,688,460 | 79,678,547 | 81,965,952 |
| 營業成本 | 44,635,412 | 55,403,820 | 55,279,360 |
| 原始認列生物資產及農產品之利益(損失) | - | - | - |
| 生物資產當期公允價值減出售成本之變動利益(損失) | - | - | - |
| 營業毛利(毛損) | 14,053,048 | 24,274,727 | 26,686,592 |
| 未實現銷貨(損)益 | - | - | - |
| 已實現銷貨(損)益 | - | - | - |
| 營業毛利(毛損)淨額 | 14,053,048 | 24,274,727 | 26,686,592 |
| 營業費用 | 6,622,730 | 8,161,164 | 8,079,809 |
| 其他收益及費損淨額 | - | - | - |
| 營業利益(損失) | 7,430,318 | 16,113,563 | 18,606,783 |
| 營業外收入及支出 | 397,778 | -1,381,250 | 5,942,629 |
| 稅前淨利(淨損) | 7,828,096 | 14,732,313 | 24,549,412 |
| 所得稅費用(利益) | 1,781,298 | 3,122,830 | 6,770,500 |
| 繼續營業單位本期淨利(淨損) | 6,046,798 | 11,609,483 | 17,778,912 |
| 停業單位損益 | - | - | - |
| 合併前非屬共同控制股權損益 | - | - | - |
| 本期淨利(淨損) | 6,046,798 | 11,609,483 | 17,778,912 |
| 其他綜合損益(淨額) | -3,447,188 | -206,823 | 297,544 |
| 合併前非屬共同控制股權綜合損益淨額 | - | - | - |
| 本期綜合損益總額 | 2,599,610 | 11,402,660 | 18,076,456 |
| 淨利(淨損)歸屬於母公司業主 | 2,501,328 | 5,346,259 | 9,843,820 |
| 淨利(淨損)歸屬於共同控制下前手權益 | - | - | - |
| 淨利(淨損)歸屬於非控制權益 | 3,545,470 | 6,263,224 | 7,935,092 |
| 綜合損益總額歸屬於母公司業主 | 816,887 | 5,785,349 | 9,634,137 |
| 綜合損益總額歸屬於共同控制下前手權益 | - | - | - |
| 綜合損益總額歸屬於非控制權益 | 1,782,723 | 5,617,311 | 8,442,319 |
| 基本每股盈餘(元) | 4 | 9 | 16 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| 營業活動之淨現金流入(流出) | 9,489,927 | 16,146,238 | 20,074,715 |
| 投資活動之淨現金流入(流出) | -38,551,299 | -29,468,317 | -73,030,269 |
| 籌資活動之淨現金流入(流出) | 3,561,121 | 33,542,281 | -1,507,745 |
| 匯率變動對現金及約當現金之影響 | 481,995 | 3,089,065 | -924,356 |
| 本期現金及約當現金增加(減少)數 | -25,018,256 | 23,309,267 | -55,387,655 |
| 期初現金及約當現金餘額 | 54,136,770 | 30,827,503 | 86,215,158 |
| 期末現金及約當現金餘額 | 29,118,514 | 54,136,770 | 30,827,503 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| 流動資產 | 92,333,499 | 102,804,167 | 101,377,922 |
| 非流動資產 | 172,203,273 | 168,527,132 | 124,117,303 |
| 資產總計 | 264,536,772 | 271,331,299 | 225,495,225 |
| 流動負債 | 73,251,137 | 77,322,585 | 87,492,231 |
| 非流動負債 | 76,860,385 | 78,454,189 | 56,008,819 |
| 負債總計 | 150,111,522 | 155,776,774 | 143,501,050 |
| 股本 | 6,412,217 | 6,412,217 | 5,862,217 |
| 權益─具證券性質之虛擬通貨 | - | - | - |
| 資本公積 | 32,697,131 | 32,671,766 | 16,955,211 |
| 保留盈餘 | 20,505,481 | 20,318,655 | 19,764,133 |
| 其他權益 | -8,068,275 | -6,454,604 | -6,457,122 |
| 庫藏股票 | -4,382,100 | -4,382,100 | -4,382,100 |
| 歸屬於母公司業主之權益合計 | 47,164,454 | 48,565,934 | 31,742,339 |
| 共同控制下前手權益 | - | - | - |
| 合併前非屬共同控制股權 | - | - | - |
| 非控制權益 | 67,260,796 | 66,988,591 | 50,251,836 |
| 權益總計 | 114,425,250 | 115,554,525 | 81,994,175 |
| 待註銷股本股數(單位:股) | 0 | 0 | 0 |
| 預收股款(權益項下)之約當發行股數(單位:股) | 0 | 0 | 0 |
| 母公司暨子公司所持有之母公司庫藏股股數(單位:股) | 27,050,000 | 27,050,000 | 27,050,000 |
| 每股參考淨值 | 76 | 79 | 56 |